131 related articles for article (PubMed ID: 24206461)
1. Health disparities in kidney disease--emerging data from the human genome.
Williams WW; Pollak MR
N Engl J Med; 2013 Dec; 369(23):2260-1. PubMed ID: 24206461
[No Abstract] [Full Text] [Related]
2. Intensive blood-pressure control in hypertensive chronic kidney disease.
Freedman BI; Sedor JR
N Engl J Med; 2010 Dec; 363(26):2565; author reply 2565-6. PubMed ID: 21175324
[No Abstract] [Full Text] [Related]
3. APOL1 and progression of nondiabetic nephropathy.
Palmer ND; Freedman BI
J Am Soc Nephrol; 2013 Sep; 24(9):1344-6. PubMed ID: 23813212
[No Abstract] [Full Text] [Related]
4. Apolipoprotein l1 and the genetic basis for racial disparity in chronic kidney disease.
Quaggin SE; George AL
J Am Soc Nephrol; 2011 Nov; 22(11):1955-8. PubMed ID: 21997393
[No Abstract] [Full Text] [Related]
5. Should kidney donors be genotyped for APOL1 risk alleles?
Freedman BI; Julian BA
Kidney Int; 2015 Apr; 87(4):671-3. PubMed ID: 25826538
[No Abstract] [Full Text] [Related]
6. APOL1 risk variants, race, and progression of chronic kidney disease.
Parsa A; Kao WH; Xie D; Astor BC; Li M; Hsu CY; Feldman HI; Parekh RS; Kusek JW; Greene TH; Fink JC; Anderson AH; Choi MJ; Wright JT; Lash JP; Freedman BI; Ojo A; Winkler CA; Raj DS; Kopp JB; He J; Jensvold NG; Tao K; Lipkowitz MS; Appel LJ; ;
N Engl J Med; 2013 Dec; 369(23):2183-96. PubMed ID: 24206458
[TBL] [Abstract][Full Text] [Related]
7. Effect of Genetic African Ancestry on eGFR and Kidney Disease.
Udler MS; Nadkarni GN; Belbin G; Lotay V; Wyatt C; Gottesman O; Bottinger EP; Kenny EE; Peter I
J Am Soc Nephrol; 2015 Jul; 26(7):1682-92. PubMed ID: 25349204
[TBL] [Abstract][Full Text] [Related]
8.
Chen TK; Appel LJ; Grams ME; Tin A; Choi MJ; Lipkowitz MS; Winkler CA; Estrella MM
Arterioscler Thromb Vasc Biol; 2017 Sep; 37(9):1765-1769. PubMed ID: 28572159
[TBL] [Abstract][Full Text] [Related]
9. Population-based risk assessment of APOL1 on renal disease.
Friedman DJ; Kozlitina J; Genovese G; Jog P; Pollak MR
J Am Soc Nephrol; 2011 Nov; 22(11):2098-105. PubMed ID: 21997396
[TBL] [Abstract][Full Text] [Related]
10. The Apolipoprotein L1 Gene and Cardiovascular Disease.
Robinson TW; Freedman BI
Methodist Debakey Cardiovasc J; 2016; 12(4 Suppl):2-5. PubMed ID: 28298955
[TBL] [Abstract][Full Text] [Related]
11. Population genetics of chronic kidney disease: the evolving story of APOL1.
Wasser WG; Tzur S; Wolday D; Adu D; Baumstein D; Rosset S; Skorecki K
J Nephrol; 2012; 25(5):603-18. PubMed ID: 22878977
[TBL] [Abstract][Full Text] [Related]
12. The new era of APOL1-associated glomerulosclerosis.
Freedman BI; Langefeld CD
Nephrol Dial Transplant; 2012 Apr; 27(4):1288-91. PubMed ID: 22302261
[No Abstract] [Full Text] [Related]
13. Examination of Potential Modifiers of the Association of APOL1 Alleles with CKD Progression.
Chen TK; Choi MJ; Kao WH; Astor BC; Scialla JJ; Appel LJ; Li L; Lipkowitz MS; Wolf M; Parekh RS; Winkler CA; Estrella MM; Crews DC
Clin J Am Soc Nephrol; 2015 Dec; 10(12):2128-35. PubMed ID: 26430087
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular twist to the rapidly evolving apolipoprotein L1 story.
Farrall M
Circ Res; 2014 Feb; 114(5):746-7. PubMed ID: 24577959
[No Abstract] [Full Text] [Related]
15. Determining the effects and challenges of incorporating genetic testing into primary care management of hypertensive patients with African ancestry.
Horowitz CR; Abul-Husn NS; Ellis S; Ramos MA; Negron R; Suprun M; Zinberg RE; Sabin T; Hauser D; Calman N; Bagiella E; Bottinger EP
Contemp Clin Trials; 2016 Mar; 47():101-8. PubMed ID: 26747051
[TBL] [Abstract][Full Text] [Related]
16. The biology of APOL1 with insights into the association between APOL1 variants and chronic kidney disease.
Madhavan SM; O'Toole JF
Clin Exp Nephrol; 2014 Apr; 18(2):238-42. PubMed ID: 24233469
[TBL] [Abstract][Full Text] [Related]
17. Gene-gene and gene-environment interactions in apolipoprotein L1 gene-associated nephropathy.
Freedman BI; Skorecki K
Clin J Am Soc Nephrol; 2014 Nov; 9(11):2006-13. PubMed ID: 24903390
[TBL] [Abstract][Full Text] [Related]
18. Testing for High-Risk APOL1 Alleles in Potential Living Kidney Donors.
Riella LV; Sheridan AM
Am J Kidney Dis; 2015 Sep; 66(3):396-401. PubMed ID: 26049628
[TBL] [Abstract][Full Text] [Related]
19. Is it variants in the apolipoprotein l1 gene, or blood pressure control, that predicts progression of nondiabetic hypertensive nephropathy in African Americans?
Cohen DL; Townsend RR
J Clin Hypertens (Greenwich); 2013 Jul; 15(7):445-6. PubMed ID: 23815529
[No Abstract] [Full Text] [Related]
20. APOL1 variants and kidney disease in people of recent African ancestry.
Genovese G; Friedman DJ; Pollak MR
Nat Rev Nephrol; 2013 Apr; 9(4):240-4. PubMed ID: 23438974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
